For example, Representative Buddy Carter (R-GA) recently introduced legislation, Drug Price Transparency in Medicaid Act (H.R. 1613), to impose a federal ban on spread pricing in Medicaid managed care and require pharmacies to be reimbursed a minimum of a drug’s national average drug acquisition cost (“NADAC”).[15] CMS establishes NADAC—a federal pricing benchmark utilized by CMS for Medicaid reimbursement based on pharmacy reports of acquisition cost to… [read post]